Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
13
NMPA:13
Drug Approvals
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20254387
- Approval Date
- May 27, 2025
NMPA
Propranolol Hydrochloride Injection
- Product Name
- 盐酸普萘洛尔注射液
- Approval Number
- 国药准字H20254202
- Approval Date
- May 20, 2025
NMPA
Nimodipine Oral Solution
- Product Name
- 尼莫地平口服溶液
- Approval Number
- 国药准字H20253289
- Approval Date
- Jan 24, 2025
NMPA
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20244807
- Approval Date
- Sep 3, 2024
NMPA
Pentoxifylline Injection
- Product Name
- 己酮可可碱注射液
- Approval Number
- 国药准字H20244248
- Approval Date
- Jun 28, 2024
NMPA
Chlorphenamine Maleate Injection
- Product Name
- 马来酸氯苯那敏注射液
- Approval Number
- 国药准字H20243659
- Approval Date
- May 8, 2024
NMPA
Salbutamol Sulfate Oral Solution
- Product Name
- 硫酸沙丁胺醇口服溶液
- Approval Number
- 国药准字H20234376
- Approval Date
- Oct 24, 2023
NMPA
Sugammadex Sodium Injection
- Product Name
- 舒更葡糖钠注射液
- Approval Number
- 国药准字H20233254
- Approval Date
- Mar 7, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found